| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/14656560802500613 |
| P698 | PubMed publication ID | 19006483 |
| P2093 | author name string | William H Ridder | |
| P2860 | cites work | Methotrexate as a first-line corticosteroid-sparing therapy in a cohort of uveitis and scleritis | Q53915477 |
| Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. | Q54643325 | ||
| Dry Eye and Dry Mouth in the Elderly | Q58760236 | ||
| Prevalence of dry eye syndrome among US women | Q28196875 | ||
| The epidemiology of dry eye in Melbourne, Australia | Q34471837 | ||
| Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia. | Q35006592 | ||
| The efficacy of sirolimus in the treatment of patients with refractory uveitis | Q35593216 | ||
| The optimal use of cyclosporin A in autoimmune diseases | Q35702904 | ||
| Ocular pharmacokinetics and safety of ciclosporin, a novel topical treatment for dry eye. | Q36068686 | ||
| The carcinogenicity of ciclosporin | Q36130177 | ||
| Topical cyclosporine for treatment of ocular surface disease | Q36632904 | ||
| Next-generation calcineurin inhibitors for ophthalmic indications | Q36964677 | ||
| Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group | Q40765221 | ||
| Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group | Q41730611 | ||
| Systemic FK506 improved tear secretion in dry eye associated with chronic graft versus host disease | Q43007372 | ||
| Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids | Q43595490 | ||
| Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. | Q44473550 | ||
| The Relationship between Habitual Patient-Reported Symptoms and Clinical Signs among Patients with Dry Eye of Varying Severity | Q44631963 | ||
| Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface | Q45158772 | ||
| Low-dose methotrexate therapy for ocular inflammatory disease | Q45693995 | ||
| Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca | Q46594199 | ||
| Immunologic and clinical evaluation of postsurgical necrotizing sclerocorneal ulceration | Q47794178 | ||
| Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study. | Q50494234 | ||
| Systemic immunomodulatory therapy in severe dry eye secondary to inflammation. | Q51750765 | ||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cyclosporine | Q367700 |
| eye disease | Q3041498 | ||
| P304 | page(s) | 3121-3128 | |
| P577 | publication date | 2008-11-12 | |
| P1433 | published in | Expert Opinion on Pharmacotherapy | Q5421212 |
| P1476 | title | Ciclosporin use in dry eye disease patients | |
| P478 | volume | 9 |
| Q38102006 | Emerging drugs for the treatment of dry eye disease | cites work | P2860 |
Search more.